NCT01571453View on ClinicalTrials.gov

Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries

PHASE3CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

Vortioxetine (Lu AA21004)

10 mg/day

DRUG

Venlafaxine extended release

150 mg/day

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT01571453 - Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries | Biotech Hunter | Biotech Hunter